Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
82.50
-2.50
(-2.94%)
As of 8:01:25 AM GMT+1. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 13 | 11 |
| Avg. Estimate | 3.46B | 3.82B | 14.81B | 16.15B |
| Low Estimate | 3.46B | 3.82B | 14.15B | 15.01B |
| High Estimate | 3.46B | 3.82B | 15.46B | 17.44B |
| Year Ago Sales | 3.73B | 3.87B | 13.72B | 14.81B |
| Sales Growth (year/est) | -7.18% | -1.19% | 8.00% | 9.01% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CFSL.F | -- | -- | -- | -- |
| S&P 500 | 16.04% | 7.30% | 10.62% | 14.21% |
Upgrades & Downgrades
| Maintains | Barclays: Overweight to Overweight | 3/4/2025 |
| Maintains | Barclays: Overweight to Overweight | 10/30/2024 |
| Upgrade | Citigroup: Neutral to Buy | 10/29/2024 |
| Maintains | Barclays: Overweight to Overweight | 7/31/2024 |
| Maintains | Barclays: Overweight to Overweight | 7/15/2024 |
| Maintains | UBS: Buy to Buy | 7/10/2024 |